Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.

Saved in:
Bibliographic Details
Title: Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.
Authors: Kofoed SV; Evaxion Biotech, Hørsholm, Denmark. svk@evaxion.ai., Barrio-Calvo M; Evaxion Biotech, Hørsholm, Denmark., Pavlidis MA; Evaxion Biotech, Hørsholm, Denmark., Kleine-Kohlbrecher D; Evaxion Biotech, Hørsholm, Denmark., Lausen M; Evaxion Biotech, Hørsholm, Denmark., Lunabjerg-Vestergaard C; Evaxion Biotech, Hørsholm, Denmark., Viborg N; Evaxion Biotech, Hørsholm, Denmark., Garde C; Evaxion Biotech, Hørsholm, Denmark., Rønø B; Evaxion Biotech, Hørsholm, Denmark., Friis S; Evaxion Biotech, Hørsholm, Denmark. sf@evaxion.ai.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Jul 24; Vol. 74 (9), pp. 276. Date of Electronic Publication: 2025 Jul 24.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40705109
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kofoed+SV%22">Kofoed SV</searchLink>; Evaxion Biotech, Hørsholm, Denmark. svk@evaxion.ai.<br /><searchLink fieldCode="AU" term="%22Barrio-Calvo+M%22">Barrio-Calvo M</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Pavlidis+MA%22">Pavlidis MA</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Kleine-Kohlbrecher+D%22">Kleine-Kohlbrecher D</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Lausen+M%22">Lausen M</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Lunabjerg-Vestergaard+C%22">Lunabjerg-Vestergaard C</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Viborg+N%22">Viborg N</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Garde+C%22">Garde C</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Rønø+B%22">Rønø B</searchLink>; Evaxion Biotech, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Friis+S%22">Friis S</searchLink>; Evaxion Biotech, Hørsholm, Denmark. sf@evaxion.ai.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2025 Jul 24; Vol. 74 (9), pp. 276. <i>Date of Electronic Publication: </i>2025 Jul 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40705109
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-025-04120-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 276
    Titles:
      – TitleFull: Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kofoed SV
      – PersonEntity:
          Name:
            NameFull: Barrio-Calvo M
      – PersonEntity:
          Name:
            NameFull: Pavlidis MA
      – PersonEntity:
          Name:
            NameFull: Kleine-Kohlbrecher D
      – PersonEntity:
          Name:
            NameFull: Lausen M
      – PersonEntity:
          Name:
            NameFull: Lunabjerg-Vestergaard C
      – PersonEntity:
          Name:
            NameFull: Viborg N
      – PersonEntity:
          Name:
            NameFull: Garde C
      – PersonEntity:
          Name:
            NameFull: Rønø B
      – PersonEntity:
          Name:
            NameFull: Friis S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 07
              Text: 2025 Jul 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 74
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1